Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013

Dr. Sulaiman Al-habib Medical Services — Q3 2020 Earnings Presentation

37 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, October 2020

  1. Slide 1: Q3 2020 Investor Presentation

    Q3 2020 Investor Presentation As of 30 September 2020

  2. Slide 2: Disclaimer

    Disclaimer Disclaimer and important information in relation to this presentation This presentation has been prepared solely for use as earnings presentation of Dr. Sulaiman Al Habib Medical Services Group Company (the “Company”). By attending or by reading this presentation, you agree to be bound by

  3. Slide 3: Presenting team

    Presenting team Nasser Al Hagbani Faisal Al Nassar Chief Executive Officer Chief Financial Officer Q3 2020 Investor Presentation 3 October 2020

  4. Slide 4: Agenda

    AGENDA Growth strategy How we performed Spotlight Technology and medical excellence Appendix #1 About HMG Appendix #2 Summarized financials Q3 2020 Investor Presentation 4 October 2020

  5. Slide 5: Growth strategy

    uuuatiu 1 = DR SULAIMAN AL HABIB Xx vexcical grou aul iacg 53a Growth strategy

  6. Slide 6: Equity story and strategy

    Equity story and strategy A well-defined strategy enhanced by our core values Vision Mission To be the most trusted healthcare provider in medical excellence and To develop and operate state of the art medical facilities and provide patient experience globally innovative healthcare services to creat

  7. Slide 7: Key messages

    Key messages A best-in-class healthcare leader with a clear growth strategy Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare provider with • Technology: Pioneer in healthcare • Efficient cash conversion cycle: shortest 25-year track record technology, aw

  8. Slide 8: HMG is contributing to the goals of Vision 2030

    HMG is contributing to the goals of Vision 2030 KSA has set a target to increase private sector participation in the healthcare industry to 35% by 2020 Commissioning Primary Long term of hospital care care Rehabilitation services and medical cities Areas of focus for privatization Home care Pharmacy

  9. Slide 9: Business structure

    Business structure A fully integrated healthcare services provider Hospitals Pharmacies HMG Solutions ▪ 7 hospitals in Saudi Arabia and ▪ Outpatient pharmacies as part of the ▪ Cloud Solutions: technology Arms Dubai hospitals including HIS, e-medicine, mobile ▪ 1,900+ beds and 1,370+ clinics • 13 ph

  10. Slide 10: Where we operate

    Where we operate With total built-up area of 689,000+ m2, HMG owns most of its hospital properties Owned Operated hospital (management agreement) Under constructions Operated ICU Implemented HIS Opened 1995 (OPD) Olaya Medical Opened 2019 Complex Khobar Opened 2008 (INP) Beds 458 Beds 260 Clinics 30

  11. Slide 11: How we performed

    uuatiu 1 3) DR SULAIMAN AL HABIB Xx vacical grou aun llacgolall How we performed

  12. Slide 12: Projects update: North Riyadh

    Projects update Solidifying our market leadership through robust expansion plan North Riyadh 100% SAR 669.7 mn SAR 2.2 bn Ownership Land Construction 2023 500 300 Expected Beds Clinics Land Design Excavation MoH license Construction Excavation Total workforce • Raft 100% Complete • 742 HMG Engineeri

  13. Slide 13: Projects update: South-West Jeddah

    Projects update Solidifying our market leadership through robust expansion plan South-West Jeddah 50% SAR 91 mn SAR 1.5 bn Ownership Land Construction 2023 330 245 Expected Beds Clinics Land Design Excavation MoH license Construction Excavation Total workforce • Shoring Wall 100% completed • 548 HMG

  14. Slide 14: Projects update: New Takhassusi Maternity and Pediatric Hospital

    Projects update Solidifying our market leadership through robust expansion plan New Takhassusi Maternity and Pediatric Hospital 100% SAR 80.8 mn SAR 391 mn Ownership Land Construction 2024 145 100 Expected Beds Clinics Land Design Excavation MoH license Construction Excavation Total workforce • Exca

  15. Slide 15: Projects update: North Jeddah

    Projects update Solidifying our market leadership through robust expansion plan North Jeddah 100% SAR 243.5 mn SAR 1.5 bn Ownership Land Construction 2024 350 270 Expected Beds Clinics Land Design Excavation MoH license Construction Medical Center at Diplomatic Quarter Leased 10 Years 17 2021 Agreem

  16. Slide 16: Highlights: Q3 2020

    Highlights: Q3 2020 Operations Mobile application Q3 2020 Strategic partnership with Dubai Total Download 735k+ downloads Growth 45% Government Workshop Spreading awareness of Booked Appointments 354k+ appointments Growth 87% breast cancer Medical excellence Transactions 97m+ transactions Growth 388

  17. Slide 17: Financial highlights: Q3 2020

    Financial highlights: Q3 2020 Revenue by segment SAR million Gross profit 60.2% Gross profit Margin +32.4% Q3 2020 559 Q3 2020 34.4% Q3 2019 349 Q3 2019 28.4% Q3 2019 Q3 2020 SAR (Millions) SAR (Millions) 40 91 3.3% 5.6% 203 261 EBITDA 53.9% EBITDA margin 16.5% 16.1% Q3 2020 416 Q3 2020 25.6% 1,227

  18. Slide 18: Healthy balance sheet / 9-month

    Healthy balance sheet / 9-month As of Sep 2019 As of Sep 2020 Total assets Total assets SAR 8.2 billion SAR 9.0 billion ROE ROA 9M 2020 20.4% 9M 2020 10.9% Cash, time 14.6% Current deposit & bank 18.4% 20.9% 18.3% 9M 2019 18.5% 9M 2019 9.8% liabilities balances Accounts receivable 18.2% 12.2% Non- R

  19. Slide 19: Low leverage levels / 9-month

    Low leverage levels / 9-month Total liabilities and equity SAR million 120.00% Total Liabilities/Total Assets Total Liabilities/Equity 100.00% 9M 2020 0.45x 9M 2020 0.81x 9M 2019 0.45x 9M 2019 0.80x 80.00% 4,532 55.5% 55.4% 4,986 60.00% Net Debt / EBITDA Net Debt / Equity 9M 2020 0.41x 9M 2020 0.12x

  20. Slide 20: Total cash dividends for shareholders: Q3 2020

    Total cash dividends for shareholders: Q3 2020 Distributed dividends Cash dividends / Q3-2020 0.60 Total distributed dividends SAR 210 million 0.50 % of capital 6% (equivalent to SAR 0.60 per share) 210 175 0.40 Eligibility date 29 October 2020 140 Date of distribution 15 November 2020 Total cash di

  21. Slide 21: Investor Relations: IR Optic

    Investor Relations: IR Optic Listening to our capital markets partners We want to know your views… Respecting your time and your preferences Ongoing effort to ensure high levels of disclosure and We fully appreciate the time constraints facing the investment transparent communications community Our

  22. Slide 22: Spotlight: Technology and medical excellence

    Spotlight Technology and medical excellence

  23. Slide 23: Developing cutting edge technology

    Developing cutting edge technology Pioneer in award-winning hospital information system and applications in the MENA region 15+ Years of 70% Saudization experience HMG Solutions’ footprint in deploying technology solutions in healthcare domain 400+ Employees 11 Products 23 International 27 Digital h

  24. Slide 24: Pioneer in healthcare technology

    Pioneer in healthcare technology Better medical outcomes, exceptional patient experience, and advanced operational practices E-medicine HIS (VIDA) Mobile application Tele-ICU ▪ First-of-its-kind electronic portal medical record anywhere anytime • The largest in the world (Guinness • Helps in storing

  25. Slide 25: Pioneer in healthcare technology (cont’d)

    Pioneer in healthcare technology (cont’d) Introducing the latest medical equipment MRI CT Scan CATH Lab The first in the region with lightweight coil High definition imaging for all body parts All heart related diagnoses in high design and noise cancelation that with exceptionally low dose of X-ray

  26. Slide 26: Pioneer in healthcare technology (cont’d)

    Pioneer in healthcare technology (cont’d) Introducing the latest medical equipment CSSD Laboratory IVF Lab The best technology in the region to Fully digital and integrated laboratories, Safe environment for embryos and disinfect and sterilize surgical instruments allowing for fast and accurate diag

  27. Slide 27: Attracting and retaining top talent

    Attracting and retaining top talent Our employees are our most valuable assets Physician qualifications 15+ average years’ experience 42% 4+ years physician 41% retention rate 17% 100+ recruiting offices 90+ nationalities 14 fellowship programs to train 50+ Saudi physicians Western (including North

  28. Slide 28: Appendix #1: About HMG

    Appendix #1 About HMG

  29. Slide 29: Strong track record in construction and ramp-up

    Strong track record in construction and ramp-up On average, opening a new hospital every 29 months, completing construction in 33 months and ramping-up in 16 months Beginning of Hospital Completion of construction Positive EBITDA construction Olaya Medical Center 1993 1995 24 months Dubai outpatient

  30. Slide 30: Diverse board of directors

    Diverse board of directors Our success is driven by our people 3 Non-Executives 3 Executives 3 Independents Dr. Sulaiman Al Habib Nasser Al Haqbani Mazen Al Rumaih Chairman Board Member and CEO Vice Chairman • Founder of HMG • Board member, Saudi Center for • Chairman, Saudi Fransi Capital • Previou

  31. Slide 31: Experienced senior management

    Experienced senior management Highly experienced, high caliber management Nasser Al Hagbani Chief Executive Officer Core functions Corporate functions Abdulwahab Abdullah Al Harbash Hesham Al Habib Faisal Al Nassar Al Abdulwahab Vice President of Vice President of Chief Financial Officer Chief Opera

  32. Slide 32: Appendix #2: Summarized financials

    Appendix #2 Summarized financials

  33. Slide 33: Summary: Balance sheet

    Summary: Balance sheet As at 30 September 2020 SAR million As of Sep 2020 As of Sep 2019 Change % Current Assets 3,266 2,989 9.25% Inventory 381 296 28.70% Investments 37 40 -7.02% Fixed Assets 5,323 5,142 3.52% Total Assets 9,007 8,467 6.37% Current Liabilities 1,653 1,495 10.55% Non-Current Liabil

  34. Slide 34: Summary: Income statement

    Summary: Income statement As at 30 September 2020 SAR million Q3 2020 Q3 2019 Change% YTD 2020 YTD 2019 Change% Revenue 1,623.9 1,226.7 32.4% 4,170.3 3,611.8 15.5% Cost of revenue (1,065.0) (877.8) 21.3% (2,851.7) (2,524.0) 13.0% Gross profit 558.9 349.0 60.2% 1,318.6 1,087.9 21.2% Selling and marke

  35. Slide 35: Summary: Cash flow statement

    Summary: Cash flow statement As at 30 September 2020 SAR million 9M 2020 9M 2019 Change % EBT before minority and Zakat 788.2 638.4 23.5% Depreciation 238.6 184.7 29.2% Accounts Receivable 291.4 (274.1) (206.3%) Inventory (84.9) (39.9) 112.5% Prepaid Expenses (2.4) (53.3) (95.4%) Accounts Payable (4

  36. Slide 36: Q&A

    Q&A Q3 2020 Investor Presentation 36 October 2020

  37. Slide 37: Dr. Sulaiman Al Habib Medical Services Group contact details

    Dr. Sulaiman Al Habib Medical Services Group Tel: +966 11 525 9999 Fax: +966 11 462 0096 Email: investor.relations@drsulaimanalhabib.com P.O. Box 301578 Riyadh 11372, Kingdom of Saudi Arabia www.hmg.com Q3 2020 Investor Presentation 37 October 2020

Dr. Sulaiman Al Habib Medical Services Group — Q3 2020 Earnings Presentation on 6ix